Neuroscience company Cognivue, Inc announced that it has partnered with the American Institute of Balance (AIB) to make its cognitive screening products and services available to the AIB provider network of certified physicians, audiologists, and physical therapists. AIB is recognized as “the leading diagnostic, treatment, and educational research center in vestibular and equilibrium sciences in the United States,” according to the announcement.
Cognivue President and CEO Tom O’Neill said, “This partnership is one of the biggest actions we have taken to bring cognitive screening into new clinical environments. With access to our Clarity and Thrive screening devices and training, AIB audiologists, physical therapists, neurologists, and ENT providers can go beyond their usual assessments to include the early detection of cognitive decline and follow-up education. We are grateful to AIB for recognizing the power and importance of having cognitive assessment become more widely available.”
Cognivue technologies are designed to give healthcare providers a useful tool for cognitive evaluation and diagnosis of various neurodegenerative and neuropsychological disorders. The Cognivue Clarity and Thrive devices provide a five- or ten-minute, self-administered computerized screening of cognitive function based on proprietary FDA-cleared technology that evaluates up to six domains and two performance parameters. The screening is “simple to implement in any clinical environment and requires minimal staff involvement,” according to the company. The devices fold up like a laptop and weigh less than eight pounds for easy portability, so they can move to various locations inside and outside of the clinic.
AIB Founder Richard E. Gans, PhD, said, “Our partnership with Cognivue gives AIB providers a proven tool to better care for their patients, letting them assess cognitive function in conjunction with checking balance and vestibular function. Early detection of decline in any of these factors can help healthcare professionals define the best course of action for positive outcomes. This aligns with our mission to provide consistent, high-quality, evidence-based care to patients and professional development to providers around the world.”
The partnership also includes a real-world data collection project among participating AIB providers to explore the potential connection between vestibular function and cognition. In addition, Cognivue and AIB will implement special promotions, direct-to-consumer marketing, and Continuing Education Unit-eligible provider events to accelerate adoption.
Source: Cognivue
